Two Sigma Investments
AERI

Two Sigma Investments’s Aerie Pharmaceuticals AERI Stock Holding History

Two Sigma Investments’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-47,529
Closed -$719K – 3216
2022
Q3 		$719K Buy
47,529
+17,700
+59% +$206K ﹤0.01% 1608
2022
Q2 		$224K Sell
29,829
-25,138
-46% -$177K ﹤0.01% 2125
2022
Q1 		$500K Buy
54,967
+36,609
+199% +$282K ﹤0.01% 2011
2021
Q4 		$129K Buy
+18,358
New +$192K ﹤0.01% 4015
2021
Q3 		– Sell
-181,018
Closed -$2.9M – 4892
2021
Q2 		$2.9M Sell
181,018
-52,011
-22% -$892K 0.01% 1578
2021
Q1 		$4.16M Buy
+233,029
New +$4.02M 0.01% 1171
2017
Q3 		– Sell
-9,713
Closed -$510K – 3324
2017
Q2 		$510K Sell
9,713
-243,477
-96% -$11.3M ﹤0.01% 2315
2017
Q1 		$11.5M Buy
+253,190
New +$11.3M 0.04% 574

Two Sigma Investments's AERI Position: Q4 2022 in Review

Two Sigma Investments sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 47,529 shares — an estimated $719K sold.

Two Sigma Investments first reported a position in AERI in Q1 2017 and held it in 8 quarters. The position peaked at $11.5M in Q1 2017. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.

  • Two Sigma Investments reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Two Sigma Investments sold 47,529 Aerie Pharmaceuticals shares in Q4 2022, an estimated $719K.
  • Two Sigma Investments first reported a position in Aerie Pharmaceuticals in Q1 2017 and held it in 8 quarters.
  • Two Sigma Investments's Aerie Pharmaceuticals position peaked at $11.5M in Q1 2017.
  • 0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.

Based on Two Sigma Investments's 13F filing for Q4 2022, filed 14 Feb 2023.